Perceptive Advisors Discloses Significant Stake in Trinity Biotech
Ticker: TRIB · Form: SC 13D · Filed: Feb 9, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | SC 13D |
| Filed Date | Feb 9, 2024 |
| Risk Level | medium |
| Pages | 8 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.0109, $0.44, $81,250,000, $22 million, $12.5 million |
| Sentiment | mixed |
Complexity: simple
Sentiment: mixed
Topics: insider-ownership, activist-investing, institutional-ownership
TL;DR
**Perceptive Advisors just revealed a big stake in Trinity Biotech, watch for potential activist moves.**
AI Summary
Perceptive Advisors LLC, led by Joseph Edelman, has filed an SC 13D for Trinity Biotech plc, indicating a significant ownership stake in the company's Class 'A' Ordinary Shares. This filing, triggered by an event on January 30, 2024, suggests that Perceptive Advisors now holds a position that could allow them to influence Trinity Biotech's strategic direction. Investors should note this as a potential catalyst for change or increased scrutiny on the company's operations, given Perceptive's reputation as an activist investor.
Why It Matters
This filing signals that a major institutional investor, Perceptive Advisors, has taken a substantial position in Trinity Biotech, potentially leading to calls for operational changes or strategic shifts that could impact the stock price.
Risk Assessment
Risk Level: medium — The involvement of an activist investor like Perceptive Advisors can introduce both upside potential and downside volatility as they may push for significant changes.
Analyst Insight
A smart investor would closely monitor news and future filings from both Trinity Biotech and Perceptive Advisors for any indications of activist campaigns or strategic changes, as this could significantly impact the stock's valuation.
Key Players & Entities
- Perceptive Advisors LLC (company) — filing party and investment advisor
- Joseph Edelman (person) — group member of the filing party
- Trinity Biotech plc (company) — subject company of the filing
- Alexander Rakitin (person) — person authorized to receive notices for Perceptive Advisors LLC
- $0.0109 (dollar_amount) — par value per share of Class 'A' Ordinary Shares
Forward-Looking Statements
- Perceptive Advisors will engage in discussions with Trinity Biotech's management regarding strategic alternatives. (Trinity Biotech plc) — medium confidence, target: Q3 2024
- Trinity Biotech's stock price will experience increased volatility due to Perceptive Advisors' involvement. (Trinity Biotech plc) — high confidence, target: Q2 2024
FAQ
What is the specific type of security that Perceptive Advisors LLC has acquired in Trinity Biotech plc?
Perceptive Advisors LLC has acquired Class 'A' Ordinary Shares, $0.0109 par value per share, of Trinity Biotech plc, which are represented by American Depository Shares.
Who is listed as a group member alongside Perceptive Credit Advisors LLC and Perceptive Credit Holdings III, L.P. in this filing?
Joseph Edelman is listed as a group member alongside Perceptive Credit Advisors LLC and Perceptive Credit Holdings III, L.P. in this filing.
What was the date of the event that required the filing of this Schedule 13D?
The date of the event which required the filing of this statement was January 30, 2024.
What is the CUSIP number associated with Trinity Biotech plc's Class 'A' Ordinary Shares?
The CUSIP number for Trinity Biotech plc's Class 'A' Ordinary Shares is 896438306.
Where is Perceptive Advisors LLC's business address located?
Perceptive Advisors LLC's business address is 51 Astor Place, 10th Floor, New York, NY 10003.
Filing Stats: 2,253 words · 9 min read · ~8 pages · Grade level 9.7 · Accepted 2024-02-09 19:51:28
Key Financial Figures
- $0.0109 — e of Issuer) Class A Ordinary Shares, $0.0109 par value per share (Title of Class o
- $0.44 — r 2,500,00 ADSs at an exercise price of $0.44 per ADS, which, in the aggregate, would
- $81,250,000 — t facility with an initial principal of $81,250,000 (the Term Loan ). In connection with th
- $22 million — estated Credit Agreement, an additional $22 million of funding was been made available to t
- $12.5 million — to the Issuer under the Term Loan, with $12.5 million to be used to acquire the Waveform asse
Filing Documents
- d763623dsc13d.htm (SC 13D) — 85KB
- d763623dex991.htm (EX-99.1) — 5KB
- 0001193125-24-030515.txt ( ) — 92KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 9, 2024 PERCEPTIVE ADVISORS LLC By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member PERCEPTIVE CREDIT ADVISORS LLC By: /s/ Joseph Edelman Name: Joseph Edelman Title: Managing Member /s/ Joseph Edelman JOSEPH EDELMAN PERCEPTIVE CREDIT HOLDINGS III, L.P. By: Perceptive Credit Opportunities GP, LLC, its general partner By: /s/ Joseph Edelman Name:Joseph Edelman Title:Managing Member